BlackRock Advisors’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$318K Sell
76,976
-4,324
-5% -$21.1K ﹤0.01% 2472
2016
Q3
$485K Hold
81,300
﹤0.01% 2191
2016
Q2
$404K Buy
81,300
+1,644
+2% +$7.2K ﹤0.01% 2232
2016
Q1
$358K Sell
79,656
-2,558
-3% -$11.6K ﹤0.01% 2247
2015
Q4
$499K Buy
82,214
+79,339
+2,760% +$549K ﹤0.01% 2075
2015
Q3
$22K Buy
+2,875
New +$20.9K ﹤0.01% 3490
2015
Q2
Sell
-2,512
Closed -$18K 3714
2015
Q1
$18K Buy
2,512
+611
+32% +$4.63K ﹤0.01% 3466
2014
Q4
$15K Hold
1,901
﹤0.01% 3558
2014
Q3
$19K Buy
+1,901
New +$19.3K ﹤0.01% 3508

Other funds holding ASPN

BlackRock Advisors's ASPN Position: Q4 2016 in Review

BlackRock Advisors reduced its Aspen Aerogels (ASPN) stake by 5.3% in Q4 2016, selling an estimated $21.1K and leaving 76,976 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #2472.

BlackRock Advisors first reported a position in ASPN in Q3 2014 and has held it in 9 quarters since. The position peaked at $499K in Q4 2015. 54 funds tracked by Wall St. Rank hold ASPN as of Q4 2016.

  • BlackRock Advisors held 76,976 shares of Aspen Aerogels worth $318K as of Q4 2016.
  • BlackRock Advisors sold 4,324 Aspen Aerogels shares in Q4 2016, an estimated $21.1K.
  • Aspen Aerogels made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2472 holding.
  • BlackRock Advisors first reported a position in Aspen Aerogels in Q3 2014 and has held it in 9 quarters since.
  • BlackRock Advisors's Aspen Aerogels position peaked at $499K in Q4 2015.
  • 54 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.